nodes	percent_of_prediction	percent_of_DWPC	metapath
Mecamylamine—CHRNB4—Nicotine Activity on Chromaffin Cells—CACNA1C—attention deficit hyperactivity disorder	0.0766	0.0936	CbGpPWpGaD
Mecamylamine—CHRNA3—Nicotine Activity on Chromaffin Cells—CACNA1C—attention deficit hyperactivity disorder	0.0701	0.0856	CbGpPWpGaD
Mecamylamine—CHRNB4—Highly sodium permeable acetylcholine nicotinic receptors—CHRNA4—attention deficit hyperactivity disorder	0.046	0.0562	CbGpPWpGaD
Mecamylamine—CHRNA3—Highly sodium permeable acetylcholine nicotinic receptors—CHRNA4—attention deficit hyperactivity disorder	0.0421	0.0514	CbGpPWpGaD
Mecamylamine—CHRNB4—Highly calcium permeable nicotinic acetylcholine receptors—CHRNA4—attention deficit hyperactivity disorder	0.0376	0.046	CbGpPWpGaD
Mecamylamine—CHRNA3—Highly calcium permeable nicotinic acetylcholine receptors—CHRNA4—attention deficit hyperactivity disorder	0.0344	0.0421	CbGpPWpGaD
Mecamylamine—CHRNB4—Highly calcium permeable postsynaptic nicotinic acetylcholine receptors—CHRNA4—attention deficit hyperactivity disorder	0.0321	0.0392	CbGpPWpGaD
Mecamylamine—CHRNA2—Highly calcium permeable nicotinic acetylcholine receptors—CHRNA4—attention deficit hyperactivity disorder	0.0307	0.0375	CbGpPWpGaD
Mecamylamine—CHRNB4—Presynaptic nicotinic acetylcholine receptors—CHRNA4—attention deficit hyperactivity disorder	0.0299	0.0365	CbGpPWpGaD
Mecamylamine—CHRNA3—Highly calcium permeable postsynaptic nicotinic acetylcholine receptors—CHRNA4—attention deficit hyperactivity disorder	0.0293	0.0358	CbGpPWpGaD
Mecamylamine—CHRNA3—Presynaptic nicotinic acetylcholine receptors—CHRNA4—attention deficit hyperactivity disorder	0.0274	0.0334	CbGpPWpGaD
Mecamylamine—CHRNB4—Acetylcholine Binding And Downstream Events—CHRNA4—attention deficit hyperactivity disorder	0.0264	0.0323	CbGpPWpGaD
Mecamylamine—CHRNA2—Highly calcium permeable postsynaptic nicotinic acetylcholine receptors—CHRNA4—attention deficit hyperactivity disorder	0.0262	0.032	CbGpPWpGaD
Mecamylamine—CHRNA2—Presynaptic nicotinic acetylcholine receptors—CHRNA4—attention deficit hyperactivity disorder	0.0244	0.0298	CbGpPWpGaD
Mecamylamine—CHRNA3—Acetylcholine Binding And Downstream Events—CHRNA4—attention deficit hyperactivity disorder	0.0242	0.0295	CbGpPWpGaD
Mecamylamine—CHRNA3—forebrain—attention deficit hyperactivity disorder	0.0221	0.122	CbGeAlD
Mecamylamine—CHRNA2—Acetylcholine Binding And Downstream Events—CHRNA4—attention deficit hyperactivity disorder	0.0216	0.0263	CbGpPWpGaD
Mecamylamine—CHRNA2—forebrain—attention deficit hyperactivity disorder	0.0206	0.114	CbGeAlD
Mecamylamine—CHRNB4—nervous system—attention deficit hyperactivity disorder	0.0196	0.108	CbGeAlD
Mecamylamine—CHRNB4—central nervous system—attention deficit hyperactivity disorder	0.0189	0.104	CbGeAlD
Mecamylamine—CHRNA3—Nicotine Activity on Dopaminergic Neurons—CHRNA4—attention deficit hyperactivity disorder	0.0175	0.0214	CbGpPWpGaD
Mecamylamine—CHRNA3—Nicotine Activity on Dopaminergic Neurons—DRD3—attention deficit hyperactivity disorder	0.0157	0.0192	CbGpPWpGaD
Mecamylamine—CHRNA3—Nicotine Activity on Dopaminergic Neurons—DRD4—attention deficit hyperactivity disorder	0.0153	0.0187	CbGpPWpGaD
Mecamylamine—CHRNB4—brain—attention deficit hyperactivity disorder	0.015	0.0826	CbGeAlD
Mecamylamine—CHRNA3—Nicotine Activity on Dopaminergic Neurons—DRD2—attention deficit hyperactivity disorder	0.0142	0.0174	CbGpPWpGaD
Mecamylamine—CHRNA3—nervous system—attention deficit hyperactivity disorder	0.012	0.0663	CbGeAlD
Mecamylamine—CHRNA3—central nervous system—attention deficit hyperactivity disorder	0.0116	0.0638	CbGeAlD
Mecamylamine—CHRNA3—cerebellum—attention deficit hyperactivity disorder	0.0113	0.0624	CbGeAlD
Mecamylamine—CHRNA2—nervous system—attention deficit hyperactivity disorder	0.0112	0.0616	CbGeAlD
Mecamylamine—CHRNA2—central nervous system—attention deficit hyperactivity disorder	0.0108	0.0594	CbGeAlD
Mecamylamine—CHRNA2—cerebellum—attention deficit hyperactivity disorder	0.0105	0.058	CbGeAlD
Mecamylamine—CHRNB4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRQ—attention deficit hyperactivity disorder	0.00952	0.0116	CbGpPWpGaD
Mecamylamine—CHRNA3—brain—attention deficit hyperactivity disorder	0.00918	0.0507	CbGeAlD
Mecamylamine—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRQ—attention deficit hyperactivity disorder	0.00871	0.0106	CbGpPWpGaD
Mecamylamine—CHRNA2—brain—attention deficit hyperactivity disorder	0.00854	0.0471	CbGeAlD
Mecamylamine—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRQ—attention deficit hyperactivity disorder	0.00777	0.00949	CbGpPWpGaD
Mecamylamine—CHRNB4—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.00716	0.00874	CbGpPWpGaD
Mecamylamine—CHRNA3—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.00654	0.00799	CbGpPWpGaD
Mecamylamine—CHRNA2—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.00584	0.00713	CbGpPWpGaD
Mecamylamine—CHRNB4—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00548	0.0067	CbGpPWpGaD
Mecamylamine—CHRNA3—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00501	0.00612	CbGpPWpGaD
Mecamylamine—CHRNA2—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00447	0.00546	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—TPH2—attention deficit hyperactivity disorder	0.00447	0.00546	CbGpPWpGaD
Mecamylamine—CHRNB4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.00419	0.00512	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—CHRNA4—attention deficit hyperactivity disorder	0.00384	0.00469	CbGpPWpGaD
Mecamylamine—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.00383	0.00468	CbGpPWpGaD
Mecamylamine—CHRNB4—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.00366	0.00447	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—SNAP25—attention deficit hyperactivity disorder	0.00357	0.00436	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—SLC6A4—attention deficit hyperactivity disorder	0.00357	0.00436	CbGpPWpGaD
Mecamylamine—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.00342	0.00418	CbGpPWpGaD
Mecamylamine—CHRNA3—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.00335	0.00409	CbGpPWpGaD
Mecamylamine—CHRNB4—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.00315	0.00385	CbGpPWpGaD
Mecamylamine—CHRNA2—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.00299	0.00365	CbGpPWpGaD
Mecamylamine—CHRNB4—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.00293	0.00358	CbGpPWpGaD
Mecamylamine—CHRNA3—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.00288	0.00352	CbGpPWpGaD
Mecamylamine—CHRNB4—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.00281	0.00343	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—MAOA—attention deficit hyperactivity disorder	0.00269	0.00328	CbGpPWpGaD
Mecamylamine—CHRNA3—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.00268	0.00327	CbGpPWpGaD
Mecamylamine—CHRNB4—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.00261	0.00319	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—BDNF—attention deficit hyperactivity disorder	0.00259	0.00317	CbGpPWpGaD
Mecamylamine—CHRNA2—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.00257	0.00314	CbGpPWpGaD
Mecamylamine—CHRNA3—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.00257	0.00314	CbGpPWpGaD
Mecamylamine—CHRNB4—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.00241	0.00295	CbGpPWpGaD
Mecamylamine—CHRNA2—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.00239	0.00292	CbGpPWpGaD
Mecamylamine—CHRNA3—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.00239	0.00292	CbGpPWpGaD
Mecamylamine—CHRNA2—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.00229	0.0028	CbGpPWpGaD
Mecamylamine—CHRNB4—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.00224	0.00274	CbGpPWpGaD
Mecamylamine—CHRNB4—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.00222	0.00271	CbGpPWpGaD
Mecamylamine—CHRNA3—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.00221	0.0027	CbGpPWpGaD
Mecamylamine—CHRNB4—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.0022	0.00269	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	0.00219	0.00268	CbGpPWpGaD
Mecamylamine—CHRNA2—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.00213	0.0026	CbGpPWpGaD
Mecamylamine—CHRNA3—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.00205	0.00251	CbGpPWpGaD
Mecamylamine—CHRNA3—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.00203	0.00248	CbGpPWpGaD
Mecamylamine—CHRNA3—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.00202	0.00246	CbGpPWpGaD
Mecamylamine—CHRNB4—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.002	0.00244	CbGpPWpGaD
Mecamylamine—CHRNA2—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.00197	0.00241	CbGpPWpGaD
Mecamylamine—CHRNA2—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.00183	0.00224	CbGpPWpGaD
Mecamylamine—CHRNA3—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.00183	0.00223	CbGpPWpGaD
Mecamylamine—CHRNA2—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.00181	0.00221	CbGpPWpGaD
Mecamylamine—CHRNA2—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.0018	0.0022	CbGpPWpGaD
Mecamylamine—CHRNB4—Neuronal System—COMT—attention deficit hyperactivity disorder	0.0017	0.00208	CbGpPWpGaD
Mecamylamine—CHRNB4—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.00169	0.00206	CbGpPWpGaD
Mecamylamine—CHRNA2—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.00163	0.00199	CbGpPWpGaD
Mecamylamine—CHRNA3—Neuronal System—COMT—attention deficit hyperactivity disorder	0.00156	0.0019	CbGpPWpGaD
Mecamylamine—CHRNA3—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.00154	0.00189	CbGpPWpGaD
Mecamylamine—CHRNA2—Neuronal System—COMT—attention deficit hyperactivity disorder	0.00139	0.00169	CbGpPWpGaD
Mecamylamine—CHRNA2—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.00138	0.00168	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	0.00116	0.00142	CbGpPWpGaD
